Center for Scientific Review; Notice of Closed Meetings, 10907-10909 [2023-03667]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 35 / Wednesday, February 22, 2023 / Notices
2644. A signed Confidential Disclosure
Agreement will be required to receive
copies of unpublished information
related to the invention.
SUPPLEMENTARY INFORMATION:
Technology description follows:
lotter on DSK11XQN23PROD with NOTICES1
Replicating RNA Vaccine for CrimeanCongo Hemorrhagic Fever Virus
Description of Technology:
Crimean-Congo hemorrhagic fever
(CCHF) is a deadly hemorrhagic fever
having a high mortality rate. The disease
results from infection of an individual
by Crimean-Congo hemorrhagic fever
virus (CCHFV), which is a tick-borne
bunyavirus endemic in Southern and
Eastern Europe, Africa, the Middle East,
and Asia. Geographically, case
distribution is consistent with the range
of Hyalomma genus ticks, the main
reservoir of CCHFV, and is likely to
expand due to climate change. Humans
may be infected from tick bites, through
contact with infected animals or animal
tissue. Nosocomial human-to-human
transmission has also been described
primarily for healthcare workers. Initial
symptoms of CCHF include acute onset
of a non-specific febrile illness
consisting of sudden fever, myalgia,
diarrhea, nausea, and vomiting. The
hemorrhagic phase is characterized by
large areas of severe bruising and
uncontrolled bleeding throughout the
body; among hospitalized patients, case
fatality rates have ranged from 9–50%.
Currently, there is no approved specific
antiviral or vaccine for CCHFV
infection.
Scientists at NIAID in collaboration
with HDT Bio have developed a
replicating RNA (repRNA) vaccine
based on Venezuelan Equine
Encephalitis Virus replicon RNA
expressing either the nucleoprotein
(repNP) or the glycoprotein precursor
(repGPC) from CCHFV alone or in
combination. In mice, the repNP
vaccine primarily elicited a robust but
non-neutralizing antibody response
while repGPC elicited primarily cellular
immunity against epitopes in the
CCHFV NSm and Gc proteins.
Vaccination with repNP or repNP +
repGPC resulted in protection against
challenge with a heterologous strain of
CCHFV in mice.
This technology is available for
licensing for commercial development
in accordance with 35 U.S.C. 209 and 37
CFR part 404, as well as for further
development and evaluation under a
research collaboration.
Potential Commercial Applications:
• Prophylactic usage against CCHFV
infections in normal or high-risk
populations.
VerDate Sep<11>2014
19:42 Feb 21, 2023
Jkt 259001
• Therapeutic treatment, alone or in
combination, in patients with CCHFV
infection.
• Assay development for
surveillance, diagnostic, and prevention
measures.
Competitive Advantages:
• Uses a cell-free system to express
antigens thereby increasing safety of the
vaccine.
• RepRNA as a platform can drive
high-level protein expression and
mimics viral replication in a single
round of replication resulting in a more
robust immune response in comparison
to DNA and mRNA platforms.
Development Stage: Pre-clinical.
Inventors: Heinz Feldmann (NIAID);
David Hawman, (NIAID); and Jesse
Erasmus (HDT Bio).
Publications: Leventhal, S. et al.,
‘‘Replicating RNA Vaccination Elicits an
Unexpected Immune Response that
Efficiently Protects Mice Against Lethal
Crimean-Congo Hemorrhagic Fever
Virus Challenge’’, EBioMedicine
82:104188 (2022).
Intellectual Property: U.S. provisional
patent application 63/365,015 filed May
19, 2022.
Licensing Contact: To license this
technology, please contact Dr. Maryann
Puglielli at (240)–627–3723, or
maryann.puglielli@nih.gov, and
reference E–103–2022.
Collaborative Research Opportunity:
The National Institute of Allergy and
Infectious Diseases is seeking statements
of capability or interest from parties
interested in collaborative research to
further develop, evaluate, or
commercialize this technology. For
collaboration opportunities, please
contact Dr. Maryann Puglielli at (240)–
627–3723, or maryann.puglielli@
nih.gov.
Dated: February 8, 2023.
Surekha Vathyam,
Deputy Director, Technology Transfer and
Intellectual Property Office, National Institute
of Allergy and Infectious Diseases.
[FR Doc. 2023–03595 Filed 2–21–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
10907
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Specialized
Centers of Research Excellence (SCORE) on
Sex Differences.
Date: March 21–22, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D.,
IRG Chief, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 6182, Bethesda, MD 20892,
(301) 435–2514, riverase@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fertility
Status as a Marker for Overall Health.
Date: March 21, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anthony Wing Sang Chan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K,
Bethesda, MD 20892, (301) 496–9392,
chana3@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Endocrine and Metabolic
Systems.
Date: March 23, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victoria Martinez Virador,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–4703, victoria.virador@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Diagnostics and Treatments (CDT).
Date: March 23–24, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Washington Marriott Georgetown,
1221 22nd Street NW, Washington, DC
20037.
Contact Person: Victor A. Panchenko,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 802B2,
E:\FR\FM\22FEN1.SGM
22FEN1
lotter on DSK11XQN23PROD with NOTICES1
10908
Federal Register / Vol. 88, No. 35 / Wednesday, February 22, 2023 / Notices
Bethesda, MD 20892, victor.panchenko@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Nephrology and Urology.
Date: March 23, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stacey Nicole Williams,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 867–5309, stacey.williams@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Health Services Research and Health
Informatics.
Date: March 23, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lauren Susan Penney,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 496–1968, penneyls@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Fellowships: Physiology and Pathobiology of
Cardiovascular and Respiratory Systems.
Date: March 23–24, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kimm Hamann, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118A,
MSC 7814, Bethesda, MD 20892, 301–435–
5575, hamannkj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Instrumentation, Environmental,
and Occupational Safety.
Date: March 23–24, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joonil Seog, SCD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, 301–402–9791, joonil.seog@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–20–
117 Maximizing Investigators’ Research
Award (MIRA) for Early Stage Investigator.
Date: March 23–24, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
19:42 Feb 21, 2023
Jkt 259001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–2381, dennis.pantazatos@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Topics in
Clinical Informatics and Data Analytics.
Date: March 23, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, 301–996–
5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflicts: Bioengineering, Biodata, and
Biomodeling Technologies.
Date: March 23, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David R. Filpula, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181,
MSC 7892, Bethesda, MD 20892, 301–435–
2902, filpuladr@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Virology.
Date: March 23, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Diana Maria Ortiz-Garcia,
Ph.D., Scientific Review Officer, The Center
for Scientific Review, The National Institutes
of Health, 6701 Rockledge Drive, Bethesda,
MD 20892, 301–594–5614, diana.ortizgarcia@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Immunology and Infectious Diseases A.
Date: March 23–24, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20876 (Virtual Meeting).
Contact Person: Deanna C. Bublitz, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–4005, deanna.bublitz@
nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Cerebrovascular Disorders and Traumatic
Brain Injury.
Date: March 23, 2023.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Paula Elyse Schauwecker,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201,
Bethesda, MD 20892, 301–760–8207,
schauweckerpe@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Cancer
Prevention.
Date: March 23, 2023.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lawrence Ka-Yun Ng,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152,
MSC 7804, Bethesda, MD 20892, 301–435–
1719, ngkl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; NS–22–034:
HEAL Meeting.
Date: March 23, 2023.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5182,
MSC 7844, Bethesda, MD 20892, (301) 408–
9664, bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Language, Communication, Vocal
Control, and Dysphagia.
Date: March 23, 2023.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, (301) 443–7193,
hargravesl@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
E:\FR\FM\22FEN1.SGM
22FEN1
Federal Register / Vol. 88, No. 35 / Wednesday, February 22, 2023 / Notices
Dated: February 16, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–03667 Filed 2–21–23; 8:45 am]
Center for Scientific Review; Notice of
Closed Meetings
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
lotter on DSK11XQN23PROD with NOTICES1
Name of Committee: National Institute on
Aging Special Emphasis Panel; Ai-ML Tools.
Date: March 13, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health,
National Institute on Aging, Gateway
Building, 7201 Wisconsin Avenue, Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Kimberly Firth, Ph.D.,
National Institutes of Health, National
Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Suite 2C212, Bethesda,
MD 20892, 301–402–7702, firthkm@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: February 15, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03640 Filed 2–21–23; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
19:42 Feb 21, 2023
Jkt 259001
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Biobehavioral Processes.
Date: March 16–17, 2023.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Jeanne M. McCaffery,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, 301–594–3854,
jeanne.mccaffery@nih.gov.
Name of Committee: Healthcare Delivery
and Methodologies Integrated Review Group;
Population and Public Health Approaches to
HIV/AIDS Study Section.
Date: March 16–17, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jose H. Guerrier, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5222,
MSC 7852, Bethesda, MD 20892, 301–435–
1137, guerriej@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
HIV Clinical Care and Health Interventions.
Date: March 21, 2023.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Campbell
Chambers, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496–5693,
jessica.chambers@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–NS–
PO 00000
Frm 00041
Fmt 4703
Sfmt 9990
10909
22–026 BRAIN Initiative: Targeted BRAIN
Circuits Projects.
Date: March 21–22, 2023.
Time: 11:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Motivated Behavior, Alcohol and
Neurotoxicology.
Date: March 21, 2023.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian H. Scott, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 827–7490, brianscott@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: HIV/AIDS Interventions and
Population and Public Health Approaches.
Date: March 21, 2023.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jessica Campbell
Chambers, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892, (301) 496–5693,
jcampbel@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 15, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–03570 Filed 2–21–23; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\22FEN1.SGM
22FEN1
]]>Agencies
[Federal Register Volume 88, Number 35 (Wednesday, February 22, 2023)]
[Notices]
[Pages 10907-10909]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-03667]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Specialized Centers of Research Excellence (SCORE) on Sex
Differences.
Date: March 21-22, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Elaine Sierra-Rivera, Ph.D., IRG Chief, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 6182, Bethesda, MD 20892, (301) 435-2514,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fertility Status as a Marker for Overall Health.
Date: March 21, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anthony Wing Sang Chan, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 809K, Bethesda, MD 20892, (301)
496-9392, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Endocrine and Metabolic Systems.
Date: March 23, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Victoria Martinez Virador, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4703,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer Diagnostics and Treatments (CDT).
Date: March 23-24, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Washington Marriott Georgetown, 1221 22nd Street NW,
Washington, DC 20037.
Contact Person: Victor A. Panchenko, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 802B2,
[[Page 10908]]
Bethesda, MD 20892, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Nephrology and Urology.
Date: March 23, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Stacey Nicole Williams, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867-5309,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Health Services Research and Health Informatics.
Date: March 23, 2023.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lauren Susan Penney, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 496-1968,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowships: Physiology and Pathobiology of Cardiovascular
and Respiratory Systems.
Date: March 23-24, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kimm Hamann, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4118A, MSC 7814, Bethesda, MD 20892, 301-435-
5575, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Instrumentation, Environmental, and
Occupational Safety.
Date: March 23-24, 2023.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Joonil Seog, SCD, Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, 301-402-9791,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-20-117 Maximizing Investigators' Research Award (MIRA)
for Early Stage Investigator.
Date: March 23-24, 2023.
Time: 9:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dennis Pantazatos, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-2381,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Topics in Clinical Informatics and Data Analytics.
Date: March 23, 2023.
Time: 9:30 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Liangbiao Zheng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD
20892, 301-996-5819, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts: Bioengineering, Biodata, and Biomodeling
Technologies.
Date: March 23, 2023.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David R. Filpula, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD
20892, 301-435-2902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Topics in Virology.
Date: March 23, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Diana Maria Ortiz-Garcia, Ph.D., Scientific
Review Officer, The Center for Scientific Review, The National
Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, 301-
594-5614, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowship: Immunology and Infectious Diseases A.
Date: March 23-24, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20876 (Virtual Meeting).
Contact Person: Deanna C. Bublitz, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-4005,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cerebrovascular Disorders and Traumatic Brain Injury.
Date: March 23, 2023.
Time: 10:30 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5201, Bethesda, MD 20892, 301-
760-8207, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Cancer Prevention.
Date: March 23, 2023.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-435-1719, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; NS-22-034: HEAL Meeting.
Date: March 23, 2023.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: John Bishop, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408-
9664, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Language, Communication, Vocal Control, and
Dysphagia.
Date: March 23, 2023.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sara Louise Hargrave, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170, Bethesda, MD 20892, (301)
443-7193, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
[[Page 10909]]
Dated: February 16, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-03667 Filed 2-21-23; 8:45 am]
BILLING CODE 4140-01-P
